Perceptive Advisors LLC acquired a new position in shares of Teladoc Inc (NYSE:TDOC) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 14,641 shares of the health services provider’s stock, valued at approximately $485,000.
A number of other hedge funds and other institutional investors have also made changes to their positions in TDOC. Rosenblum Silverman Sutton S F Inc. CA lifted its holdings in shares of Teladoc by 2.7% during the 2nd quarter. Rosenblum Silverman Sutton S F Inc. CA now owns 67,395 shares of the health services provider’s stock valued at $2,339,000 after buying an additional 1,800 shares during the last quarter. Bank of Montreal Can lifted its holdings in shares of Teladoc by 214.2% during the 2nd quarter. Bank of Montreal Can now owns 3,516 shares of the health services provider’s stock valued at $123,000 after buying an additional 2,397 shares during the last quarter. Legal & General Group Plc lifted its holdings in shares of Teladoc by 66.3% during the 1st quarter. Legal & General Group Plc now owns 6,137 shares of the health services provider’s stock valued at $154,000 after buying an additional 2,446 shares during the last quarter. Raymond James Trust N.A. lifted its holdings in shares of Teladoc by 36.2% during the 3rd quarter. Raymond James Trust N.A. now owns 9,943 shares of the health services provider’s stock valued at $330,000 after buying an additional 2,643 shares during the last quarter. Finally, American International Group Inc. lifted its holdings in shares of Teladoc by 8.1% during the 3rd quarter. American International Group Inc. now owns 36,079 shares of the health services provider’s stock valued at $1,196,000 after buying an additional 2,697 shares during the last quarter.
Teladoc Inc (NYSE:TDOC) traded down $0.20 on Monday, reaching $33.55. The company had a trading volume of 1,198,500 shares, compared to its average volume of 970,639. Teladoc Inc has a 12-month low of $15.65 and a 12-month high of $37.90. The company has a debt-to-equity ratio of 0.83, a current ratio of 5.08 and a quick ratio of 5.08.
Teladoc (NYSE:TDOC) last posted its earnings results on Wednesday, November 1st. The health services provider reported ($0.55) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.30) by ($0.25). The company had revenue of $68.70 million during the quarter, compared to analyst estimates of $67.53 million. Teladoc had a negative return on equity of 21.59% and a negative net margin of 39.61%. The firm’s revenue for the quarter was up 112.0% compared to the same quarter last year. During the same quarter last year, the firm posted ($0.33) earnings per share. equities analysts expect that Teladoc Inc will post -1.57 earnings per share for the current year.
TDOC has been the subject of several research reports. BidaskClub lowered Teladoc from a “hold” rating to a “sell” rating in a report on Tuesday, August 15th. Cantor Fitzgerald reiterated a “hold” rating on shares of Teladoc in a report on Monday, August 28th. KeyCorp reiterated a “buy” rating and set a $37.00 price target on shares of Teladoc in a report on Sunday, September 17th. Robert W. Baird lowered Teladoc from an “outperform” rating to a “neutral” rating and lifted their price target for the company from $14.00 to $36.00 in a report on Monday, September 18th. Finally, Zacks Investment Research upgraded Teladoc from a “sell” rating to a “hold” rating in a report on Thursday, September 21st. One research analyst has rated the stock with a sell rating, four have given a hold rating and ten have assigned a buy rating to the company. Teladoc presently has a consensus rating of “Buy” and an average target price of $39.15.
In other Teladoc news, VP Mark Hirschhorn sold 25,000 shares of Teladoc stock in a transaction that occurred on Friday, September 22nd. The stock was sold at an average price of $31.93, for a total value of $798,250.00. Following the transaction, the vice president now directly owns 64,987 shares of the company’s stock, valued at approximately $2,075,034.91. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, CEO Jason N. Gorevic sold 20,000 shares of Teladoc stock in a transaction that occurred on Thursday, November 2nd. The stock was sold at an average price of $32.10, for a total value of $642,000.00. Following the completion of the transaction, the chief executive officer now directly owns 838,261 shares in the company, valued at $26,908,178.10. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 265,000 shares of company stock worth $8,697,400. Company insiders own 4.47% of the company’s stock.
Teladoc, Inc is a telehealth company. The Company offers telehealth platform, delivering on-demand healthcare anytime, anywhere, through mobile devices, the Internet, video and phone. The Company’s solution connects its Members, with its over 3,000 board certified physicians and behavioral health professionals treating a range of conditions and cases from acute diagnoses, such as upper respiratory infection, urinary tract infection and sinusitis to dermatological conditions, anxiety and smoking cessation.
Want to see what other hedge funds are holding TDOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teladoc Inc (NYSE:TDOC).
Receive News & Ratings for Teladoc Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Inc and related companies with MarketBeat.com's FREE daily email newsletter.